The investments are one of many initiatives ranging from retail to workforce and philanthropy that exemplify the company’s longstanding commitment…
Browsing: Pharmaceuticals
If approved, vorasidenib would be the first targeted therapy in IDH-mutant diffuse glioma, a malignant and incurable brain tumor In…
The firm analyzes preliminary results from three investigational clinical trials across the globe NEW HAVEN, Conn., Feb. 21, 2024 /PRNewswire/…
JERSEY CITY, N.J., Feb. 21, 2024 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report…
AMTAGVI est le premier et le seul traitement individualisé par lymphocytes T à recevoir l’approbation de la FDA américaine pour traiter une…
OSAKA, Japan, Feb. 20, 2024 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced…
GAITHERSBURG, Md., Feb. 20, 2024 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant,…
KRAKOW, Poland, Feb. 14, 2024 /PRNewswire/ — Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel…
ROCKVILLE, Md., USA and SUZHOU, China, Feb. 13, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing…